The company will host a webcast to announce its 2025 fourth-quarter and full-year results. A bullish investment thesis suggests the stock may be significantly undervalued, trading at a 42% discount to a fair value estimate of $106. Despite recent challenges, including an 8.2% stock decline over three months due to falling cigarette volumes and increased competition, the stock recently advanced against a declining market. It is highlighted as a reliable income source with attractive valuation metrics.